Back to search
Hypersensitivity, Immediate
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hypersensitivity, Immediate trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hypersensitivity, Immediate trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
ARES is a multi-centre, retrospective-prospective, non-comparative and non-interventional (observational) cohort study involving primary and secondary data coll…
Background: Eosinophilic esophagitis (EoE) is a disease that causes inflammation in the esophagus. The esophagus is the tube that moves food from the mouth to…
This study will investigate how, why and under what conditions eosinophils (a type of white blood cell) become activated and will examine their function in immu…
Background: Autosomal dominant hyper-IgE syndrome (HIES), also called Job syndrome, is a genetic disorder that affects the immune system. It can cause skin and…
The study will be based from a newly formed NHS service, the children's environmental health service. Participants will be children with a known chronic respira…
In adolescents treated with dupilumab, clinical trials showed significant improvement of atopic dermatitis (AD) signs and symptoms, with a good safety profile.…
This is a parallel, Phase 3, 2-arm study to evaluate the efficacy and long-term safety of dupilumab treatment in children 2 to \<6 years of age with uncontrolle…
The overall aim of the study is to determine the clinical efficacy and mechanisms of action of anti-IL-4a (dupilumab) as treatment for patients with Chronic Rhi…